CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 88 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,385,000 | -61.9% | 277,611 | -3.6% | 0.00% | -100.0% |
| Q4 2020 | $3,639,000 | +28.3% | 287,910 | -0.3% | 0.00% | 0.0% |
| Q3 2020 | $2,836,000 | -16.1% | 288,816 | -15.0% | 0.00% | 0.0% |
| Q2 2020 | $3,380,000 | -0.2% | 339,749 | -11.3% | 0.00% | -50.0% |
| Q1 2020 | $3,386,000 | +11.6% | 383,035 | +16.4% | 0.00% | +100.0% |
| Q4 2019 | $3,035,000 | +16.2% | 328,958 | -26.0% | 0.00% | 0.0% |
| Q3 2019 | $2,612,000 | -52.7% | 444,370 | -3.4% | 0.00% | -50.0% |
| Q2 2019 | $5,523,000 | – | 460,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |